EQUINE INFLUENZA 1 EI is an acute contagious

  • Slides: 21
Download presentation
EQUINE INFLUENZA 1

EQUINE INFLUENZA 1

 EI is an acute contagious viral respiratory disease of equines characterized clinically by

EI is an acute contagious viral respiratory disease of equines characterized clinically by severe cough, mild fever, serous to mucopurulent discharges. 2

Influenza (EI) is a highly contagious though rarely fatal respiratory disease of horses, donkeys

Influenza (EI) is a highly contagious though rarely fatal respiratory disease of horses, donkeys and mules and other equidae. 3

The disease has been recorded throughout history, and when horses were the main draft

The disease has been recorded throughout history, and when horses were the main draft animals, outbreaks of EI crippled the economy. Nowadays outbreaks still have a severe impact on the horse industry 4

Synonyms Infectious equine bronchitis Laryngotracheo bronchitis Epidemic cough 5

Synonyms Infectious equine bronchitis Laryngotracheo bronchitis Epidemic cough 5

Etiology EI is caused by two subtypes of influenza A viruses: H 7 N

Etiology EI is caused by two subtypes of influenza A viruses: H 7 N 7 and H 3 N 8, of the family Orthomyxoviridae. They are related to but distinct from the viruses that cause human and avian influenza. 6

 Distribution: World wide distributed Australia and New Zealand are free 7

Distribution: World wide distributed Australia and New Zealand are free 7

 Sources of infection q. The main source of infection is the infected horse

Sources of infection q. The main source of infection is the infected horse shedding the virus in nasal secretions. 8

MODE OF TRANSMISSION Inhalation 9

MODE OF TRANSMISSION Inhalation 9

SUSCEPTIBLE ANIMALS All equidae are susceptible. 10

SUSCEPTIBLE ANIMALS All equidae are susceptible. 10

Factors influencing susceptibility All ages and sexes are susceptible to natural infection. 11

Factors influencing susceptibility All ages and sexes are susceptible to natural infection. 11

E. VALUE It interrupts racing and training schedules 12

E. VALUE It interrupts racing and training schedules 12

 After Pathogenesis inhalation, the virions would replicate in the epithelial cells lining the

After Pathogenesis inhalation, the virions would replicate in the epithelial cells lining the upper respiratory tract leading to damage to cilia, hyperaemia, edema and desquamation and erosion of the epithelial cells. The horse will show clinical signs of typical respiratory disease. It may lead to bronchopneumonia. 13

Clinical signs IP 1 -3 days. High morbidity rate 100%. Low mortality rate except

Clinical signs IP 1 -3 days. High morbidity rate 100%. Low mortality rate except in young foals. 14

 • • • Sudden Cough up to 3 wks. Pyrexia Watery nasal discharge.

• • • Sudden Cough up to 3 wks. Pyrexia Watery nasal discharge. Depressed Weakness, stiffness Anorexia Conjunctivitis Painful sub maxillary LNs with or without enlargement 15

DIAGNOSIS Case history Clinical signs Viral isolation and identification. 16

DIAGNOSIS Case history Clinical signs Viral isolation and identification. 16

TREATMENT There is no specific treatment. 17

TREATMENT There is no specific treatment. 17

Prevention and control • Servac monovalent inactivated freeze dried equine influenza vaccine • Type

Prevention and control • Servac monovalent inactivated freeze dried equine influenza vaccine • Type of vaccine: inactivated freeze dried vaccine. • Host: equines. • Packing unit: one vial (one dose) freeze dried vaccine. one vial (2 ml) of diluents (adjuvant). 18

 • Dosage: 2 ml of reconstituted vaccine. • Method of use: reconstituted vaccine

• Dosage: 2 ml of reconstituted vaccine. • Method of use: reconstituted vaccine should be injected deep I/M in the last third of the neck. • Vaccination with 2 doses within 1 -month interval then revaccinated after 6 month then repeated annually. • Foals from vaccinated mares vaccinated 6 month with 2 doses within 1 -month interval then revaccinated after 6 month then repeated annually. 19

 Foals from unvaccinated mare vaccinated at 3 month with 2 doses within 1

Foals from unvaccinated mare vaccinated at 3 month with 2 doses within 1 -month interval then revaccinated after 6 month then repeated annually Racing horse vaccinated every 4 -6 month. Pregnant mares vaccinated 4 -6 month before parturation. 20

 Storage: stored at temp 4 -8ºC. Adverse effect: no effect. Recommendations: The reconstituted

Storage: stored at temp 4 -8ºC. Adverse effect: no effect. Recommendations: The reconstituted vaccine used immediately within 1 hour. Never exposure to direct sunlight or heat. Vaccination of healthy horses only 21